Aura Biosciences (AURA) Stock Price, Quote, News & History | Benzinga

Aura Biosciences Inc (AURA) Stock Price, Quote, News & History

AURANASDAQ

Trade with Public

Trade with Public

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$6.73

Close

-

Volume / Avg.

173.71K / 474.62K

Day Range

$6.42 - $6.73

52 Wk Range

4.73 - 9.54

Market Cap

$672.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

3.66%

Days to Cover

2.78

Recent Aura Biosciences Inc News

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease

Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile.

Vandana Singh

Aura Biosciences Touts Promising Data From Eye Cancer Candidate

Aura Biosciences announced promising Phase 2 results for bel-sar in treating melanoma, achieving 80% tumor control.

Vandana Singh

Why Aura Biosciences Stock Hit A New 52-Week Low Today

Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pricing of its public offering of common st

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-91.28M

Investing Cash Flow (TTM)

60.68M

Financing Cash Flow (TTM)

77.36M

Free Cash Flow (TTM)

-91.64M

Capital Expenditure (TTM)

-362.00K

Net Change in Cash (TTM)

46.76M

Analyst Trends and Forecast

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$645.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.39

Earnings Yield % (TTM)

-25.79%

Earnings Yield % (FWD)

-30.17%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$84.79M

Debt to Equity

0.16

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$6.73

Close

-

Volume / Avg.

173.71K / 474.62K

Day Range

$6.42 - $6.73

52 Wk Range

4.73 - 9.54

Market Cap

$672.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

3.66%

Days to Cover

2.78

About

Sector

Health Care

Industry

Biotechnology

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical de...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aura Biosciences (AURA) stock?

A

You can purchase shares of Aura Biosciences (NASDAQ:AURA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aura Biosciences (AURA) competitors?

A

There are no as such competitors for Aura Biosciences.

Q

What is the forecast, or price target, for Aura Biosciences (AURA) stock?

A

Aura Biosciences has a consensus price target of $21.20.

Q

What is the current price for Aura Biosciences (AURA)?

A

The stock price for Aura Biosciences (NASDAQ: AURA) is $6.505 last updated June 8, 2026 at 3:47 PM EDT.

Q

Does Aura Biosciences (AURA) pay a dividend?

A

There are no upcoming dividends for Aura Biosciences.

Q

When is Aura Biosciences (NASDAQ:AURA) reporting earnings?

A

Aura Biosciences does not have any upcoming earnings scheduled.

Q

Is Aura Biosciences (AURA) going to split?

A

There is no upcoming split for Aura Biosciences.

Q

What sector and industry does Aura Biosciences (AURA) operate in?

A

Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.